Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B E Huber

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 1, 1989
Therapeutic opportunities involving cellular oncogenes: novel approaches fostered by biotechnologyB E Huber
Molecular Pharmacology|April 1, 1992
Late-stage spermatids are characterized by expression of the "liver-specific" asialoglycoprotein receptor, RHL-1B E Huber
The Journal of Biological Chemistry|February 16, 1996
Cytosine deaminase gene as a positive selection markerK Wei, B E Huber
Cancer Research|November 1, 1983
Tumor promoter actions on rat embryonic development in cultureB E Huber, N A Brown
Human Gene Therapy|April 1, 1993
Generation of a transgenic model for retrovirus-mediated gene therapy for hepatocellular carcinoma is thwarted by the lack of transgene expressionC A Richards, B E Huber
Cancer Research|July 1, 1987
Analysis of c-myc expression in a human hepatoma cell lineB E Huber, S S Thorgeirsson
Molecular Pharmacology|March 1, 1993
A first step in the development of gene therapy for colorectal carcinoma: cloning, sequencing, and expression of Escherichia coli cytosine deaminaseE A Austin, B E Huber
Gene|October 21, 1994
The major form of the murine asialoglycoprotein receptor: cDNA sequence and expression in liver, testis and epididymisR S Monroe, B E Huber
Journal of Drug Targeting|January 1, 1996
Regulated expression of artificial chimeric genes contained in retroviral vectors: implications for virus-directed enzyme prodrug therapy (VDEPT) and other gene therapy applicationsB E Huber, C A Richards
Research Communications in Chemical Pathology and Pharmacology|July 1, 1985
12-O-Tetradecanoyl-phorbol-13-acetate (TPA) induced congenital kidney defects and embryomortality in the CD-1 mouseB E Huber, N A Brown
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 1, 1989
Therapeutic opportunities involving cellular oncogenes: novel approaches fostered by biotechnologyB E Huber
Molecular Pharmacology|April 1, 1992
Late-stage spermatids are characterized by expression of the "liver-specific" asialoglycoprotein receptor, RHL-1B E Huber
The Journal of Biological Chemistry|February 16, 1996
Cytosine deaminase gene as a positive selection markerK Wei, B E Huber
Cancer Research|November 1, 1983
Tumor promoter actions on rat embryonic development in cultureB E Huber, N A Brown
Human Gene Therapy|April 1, 1993
Generation of a transgenic model for retrovirus-mediated gene therapy for hepatocellular carcinoma is thwarted by the lack of transgene expressionC A Richards, B E Huber
Cancer Research|July 1, 1987
Analysis of c-myc expression in a human hepatoma cell lineB E Huber, S S Thorgeirsson
Molecular Pharmacology|March 1, 1993
A first step in the development of gene therapy for colorectal carcinoma: cloning, sequencing, and expression of Escherichia coli cytosine deaminaseE A Austin, B E Huber
Gene|October 21, 1994
The major form of the murine asialoglycoprotein receptor: cDNA sequence and expression in liver, testis and epididymisR S Monroe, B E Huber
Journal of Drug Targeting|January 1, 1996
Regulated expression of artificial chimeric genes contained in retroviral vectors: implications for virus-directed enzyme prodrug therapy (VDEPT) and other gene therapy applicationsB E Huber, C A Richards
Research Communications in Chemical Pathology and Pharmacology|July 1, 1985
12-O-Tetradecanoyl-phorbol-13-acetate (TPA) induced congenital kidney defects and embryomortality in the CD-1 mouseB E Huber, N A Brown
Pageof 5